IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider and approve Audited Financial ....
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IOL Chemicals & Pharmaceuticals has informed the exchanges that its Board of Directors will meet on Friday, 16th May 2025 to consider and approve the Audited Financial Results for the quarter and financial year ended 31st March 2025. This is a standard SEBI-mandated advance intimation under Regulation 29 of the LODR Regulations, 2015. The trading window for designated persons, which was already closed from 1st April 2025, will remain shut until 48 hours after the results are announced, reopening on 19th May 2025. No actual financial numbers or business commentary have been disclosed in this filing.
This is a routine procedural filing and has no direct impact on shareholders. Investors should watch for the actual Q4 and FY25 results on 16th May 2025 to gauge the company's full-year performance, margin trends, and any management commentary on growth outlook.